Worth reading
41Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 7th and 8th Stock Acquisition Rights issued through a third-party allotment (with an option to elect an exercise price adjustment provision) and the 9th Stock Acquisition Rights (fixed exercise price type)
発行・処分する株式数
Shares delivered during the month: 7th series 0 shares, 8th series 0 shares, 9th series 0 shares
発行済株式総数
Exercise ratio during the month: 7th series 0.00%, 8th series 0.00%, 9th series 0.00%. Cumulative exercise ratio: 7th series 2.33%, 8th series 0.00%, 9th series 0.00%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
7th: ¥3,050; 8th: ¥3,500; 9th: ¥4,000. The 7th and 8th Stock Acquisition Rights include the right to convert to stock acquisition rights with an adjustable exercise price, while the 9th Stock Acquisition Rights are fixed exercise price type.
Number of Stock Acquisition Rights
Total issued: Not disclosed. Number exercised during the month: 7th series 0, 8th series 0, 9th series 0. Unexercised balance at month-end: 7th series 1,465, 8th series 1,500, 9th series 750
Procedures under the Corporate Code of Conduct
Details of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc.
Most recent equity financing
31 July 2026: Issuance through a third-party allotment of the 7th, 8th and 9th series of stock acquisition rights. Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 7th and 8th Stock Acquisition Rights issued through a third-party allotment (with an option to elect an exercise price adjustment provision) and the 9th Stock Acquisition Rights (fixed exercise price type) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 7th series 0 shares, 8th series 0 shares, 9th series 0 shares |
| Dilution Rate | Exercise ratio during the month: 7th series 0.00%, 8th series 0.00%, 9th series 0.00%. Cumulative exercise ratio: 7th series 2.33%, 8th series 0.00%, 9th series 0.00% |
| Total number of issued shares | 1,521,500 shares (including 264 treasury shares) → Not disclosed |
| Exercise price | 7th: ¥3,050; 8th: ¥3,500; 9th: ¥4,000. The 7th and 8th Stock Acquisition Rights include the right to convert to stock acquisition rights with an adjustable exercise price, while the 9th Stock Acquisition Rights are fixed exercise price type. |
| Number of Stock Acquisition Rights | Total issued: Not disclosed. Number exercised during the month: 7th series 0, 8th series 0, 9th series 0. Unexercised balance at month-end: 7th series 1,465, 8th series 1,500, 9th series 750 |
| Procedures under the Corporate Code of Conduct | Details of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc. |
| Most recent equity financing | 31 July 2026: Issuance through a third-party allotment of the 7th, 8th and 9th series of stock acquisition rights. Amount: Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.